ArticleNeuro-oncology2015

A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients with refractory primary central nervous system tumors: a pediatric brain tumor consortium study.

Lindsay B Kilburn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.